Leukotriene B4 and prostaglandin E2-like activity in synovial fluid in osteoarthritis
- 1 April 1990
- journal article
- research article
- Published by Elsevier in Prostaglandins, Leukotrienes & Essential Fatty Acids
- Vol. 39 (4) , 253-254
- https://doi.org/10.1016/0952-3278(90)90002-3
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- How are Prostaglandins and Leukotrienes Involved in Immunological Alterations?Published by Wolters Kluwer Health ,1984
- Leukotriene B4, a mediator of inflammation present in synovial fluid in rheumatoid arthritis.Annals of the Rheumatic Diseases, 1983
- LEUKOTRIENESAnnual Review of Biochemistry, 1983
- The release of leukotriene B4 during experimental inflammationBiochemical Pharmacology, 1983
- An in vivo model for measuring antigen‐induced SRS‐A‐mediated bronchoconstriction and plasma S RS‐ A levels in the guinea‐pigBritish Journal of Pharmacology, 1983
- Regulation of leukocyte and platelet lipoxygenases by hydroxyeicosanoidsBiochemical Pharmacology, 1982
- Inhibition of leukotriene biosynthesis by acetylenic analogsBiochemical and Biophysical Research Communications, 1982
- Leukotrienes are potent constrictors of human bronchiNature, 1980
- Lipoxygenation of arachidonic acid as a source of polymorphonuclear leukocyte chemotactic factors in synovial fluid and tissue in rheumatoid arthritis and spondyloarthritis.Journal of Clinical Investigation, 1980
- Prostaglandins released by the SpleenNature, 1968